Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease

Journal of Clinical Oncology

Volumn 15, Issue 9, 1997, Pages 3060-3066

  Bodis, Stephan ^a   Kraus, Madeleine D ^a   Pinkus, Geraldine ^a   Silver, Barbara ^a   Kadin, Marshall E ^a   Canellos, George P ^a   Shulman, Lawrence N ^a   Tarbell, Nancy J ^a   Mauch, Peter M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HODGKIN DISEASE; HUMAN; IMMUNOPHENOTYPING; LYMPH NODE METASTASIS; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; OUTCOMES RESEARCH; PRIORITY JOURNAL; REED STERNBERG CELL; SURVIVAL RATE; T LYMPHOCYTE ACTIVATION;

EID: 0030747027     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.9.3060     Document Type: Article

References (45)

1. Dawson P, Harrison C: A clinicopathological study of benign Hodgkin's disease. J Clin Pathol 14:219-231, 1961
2. Colby T, Hoppe R, Warnke R: Hodgkin's disease: A clinicopathologic study of 659 cases. Cancer 49:1848-1858, 1982
3. Tubiana M, Henry-Amar M, Carde P, et al: Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987. Blood 73:47-56, 1989
4. Regula D, Hoppe R, Weiss L: Nodular and diffuse types of lymphocyte predominance Hodgkin's disease. N Engl J Med 318:214-220, 1988
5. Mauch P, Kalish L, Kadin M, et al: Patterns of presentation of Hodgkin's disease. Cancer 71:2062-2071, 1993
6. Borg-Grech A, Radford J, Crowther D, et al: A comparative study of the nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease. J Clin Oncol 7:1303-1309, 1989
7. Bishop P, Harris M, Smith A, et al: Immunophenotypic study of lymphocyte predominance Hodgkin's disease. Histopathology 18:19-24, 1991
8. Chittal S, Caveriviere P, Schwarting R, et al: Monoclonal antibodies in the diagnosis of Hodgkin's disease. Am J Surg Pathol 12:9-12, 1988
9. Poppema S: Lymphocyte-predominance Hodgkin's disease. Semin Diagn Pathol 9:257-264, 1992
10. Lukes R, Butler J, Hicks E: Natural history of Hodgkin's disease as related to pathological picture. Cancer 19:317-344, 1966
11. Lukes R, Craver L, Hall T, et al: Report of the Nomenclature Committee. Cancer Res 26:1311, 1966
12. Pinkus G, Thomas P, Said J: LeuM1, a marker for Reed Sternberg cells in Hodgkin's disease: An immunoperoxidase study of paraffin embedded tissues. Am J Pathol 119:244-252, 1985
13. Pinkus G, Said J: Hodgkin's disease, lymphocyte predominance type, nodular - Further evidence of a B cell derivation: L + H variants of Reed-Sternberg cells express L26, a pan B cell marker. Am J Pathol 133:211-217, 1988
14. Schmid C, Sargeni C, Isaacson P: L and H cells of nodular lymphocyte predominant Hodgkin's disease show immunoglobulin light chain reaction. Am J Pathol 139:1281-1289, 1991
15. Stein H, Hansmann M, Lennert K, et al: Reed-Sternberg and Hodgkin's cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain. Am J Clin Pathol 86:292-297, 1986
16. Zukerberg LR, Collins AB, Ferry JA, et al: Coexpression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin's disease. Am J Pathol 139:475-483, 1991
17. Mason D, Banks P, Chan J, et al: Nodular lymphocyte predominance Hodgkin's disease: A distinct clinicopathologic entity. Am J Surg Pathol 18:526-530, 1994
18. Pinkus G, Said J: Hodgkin's disease, lymphocyte predominance type, nodular - A distinct entity? Am J Pathol 118:1-6, 1985
19. Hansmann M-L, Stein H, Dallenbach F, et al: Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma). A variant of the B-cell-derived nodular type. Am J Pathol 138:29-36, 1991
20. Variakojis D, Anastasi J: Unresolved issues concerning Hodgkin's disease and its relationship to non-Hodgkin's lymphoma. Am J Clin Pathol 99:436-444, 1993
21. Delabie J, Vandenberghe E, Kennes C, et al: Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype. Am J Surg Pathol 16:37-48, 1992
22. Nicholas D, Harris S, Wright D: Lymphocyte predominance Hodgkin's disease - An immunohistochemical study. Histopathology 16:157-165, 1990
23. Algara P, Martinez P, Sanchez L: Lymphocyte predominance Hodgkin's disease (nodular paragranuloma) - A bcl-2 negative germinal center lymphoma. Histopathology 19:69-75, 1991
24. Hansmann M-L, Shibata D, Lorenzen J: Incidence of Epstein Barr virus, bcl-2 expression, and chromosomal translocation t(14,18) in large cell lymphoma associated with paragranuloma (lymphocyte predominance Hodgkin's disease). Hum Pathol 25:240-243, 1994
25. Said J, Sassoon A, Shintaku I, et al: Absence of bcl-2 major breakpoint region and JH gene rearrangement in lymphocyte predominance Hodgkin's disease. Am J Pathol 138:261-264, 1991
26. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
27. Peto R, Peto J: Asymptotically efficient rank invariant test procedures (with discussion). J R Stat Soc A 135:185-206, 1972
28. Chittal S, Alard C, Rossi J-F: Further phenotypic evidence that nodular, lymphocyte-predominant Hodgkin's disease is a large B-cell lymphoma in evolution. Am J Surg Pathol 14:1024-1035, 1990
29. Delabie J, Tierens A, Wu G, et al: Lymphocyte predominant Hodgkin's disease: Lineage and clonality determination using a single-cell assay. Blood 84:3291-3298, 1994
30. Gelb A, Dorfman R, Warnke R: Co-existence of nodular lymphocyte predominance Hodgkin's disease and Hodgkin's disease of the usual type. Am J Surg Pathol 17:364-374, 1993
31. Grossman DM, Hanson CA, Schnitzer B: Simultaneous lymphocyte predominant Hodgkin's disease and large-cell lymphoma. Am J Surg Pathol 15:668-676, 1991
32. Jaffe E, Zarate-Osorno A, Kingma D: The interrelationship between Hodgkin's disease and non Hodgkin's lymphomas. Ann Oncol 5:7-11, 1994
33. Sundeen J, Cossman J, Jaffe E: Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent "large cell lymphoma": Histological progression or composite malignancy? Am J Surg Pathol 12:599, 1988
34. Harris N, Jaffe E, Stein H, et al: Perspective: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
35. Momose H, Chen Y, Ben-Ezra J, et al: Nodular lymphocyte predominant Hodgkin's disease: Study of immunoglobulin light chain protein and mRNA expression. Hum Pathol 23:1115-1119, 1992
36. Crennan E, D'Costa I, Liew KH, et al: Lymphocyte predominant Hodgkin's disease: A clinicopathologic comparative study of histologic and immunophenotypic subtypes. Int J Radiat Oncol Biol Phys 31:333-337, 1995
37. Pappa VI, Norton AJ, Gupta RK, et al: Nodular type of lymphocyte predominant Hodgkin's disease. A clinical study of 50 cases. Ann Oncol 6:559-565, 1995
38. Tefferi A, Zellers R, Banks P, et al: Clinical correlates of distinct immunophenotypic and histologic subcategories of lymphocyte-predominance Hodgkin's disease. J Clin Oncol 8:1959-1965, 1990
39. Trudel M, Krikorian J, Neiman R: Lymphocyte predominance Hodgkin's disease. Cancer 59:99-106, 1987
40. Wickert R, Weisenburger D, Tierens A, et al: Clonal relationship between lymphocyte predominance Hodgkin's disease and concurrent or subsequent large-cell lymphoma of B lineage. Blood 86:2312, 1995
41. Pan L, Diss T, Peng A, et al: Nodular lymphocyte predominance Hodgkin's disease: A monoclonal or polyclonal B-cell disorder. Blood 87:2428-2434, 1996
42. Mauch P, Larson D, Osteen R, et al: Prognostic factors for positive surgical staging in patients with Hodgkin's disease. J Clin Oncol 8:257-265, 1990
43. Leibenhaut M, Hoppe R, Efron B, et al: Prognostic indicators of laparotomy findings in clinical stage I-II supradiaphragmatic Hodgkin's disease. J Clin Oncol 7:81-91, 1989
44. Mauch P, Tarbell N, Weinstein H, et al: Stage IA and IIA supradiaphragmatic Hodgkin's disease: Prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. J Clin Oncol 6:1576-1583, 1988
45. Duhmke E, Diehl V, Loeffler M, et al: Randomized trial with early-stage Hodgkin's disease testing 30 Gy vs 40 Gy extended field radiotherapy alone. Int J Radiat Oncol Biol Phys 36:305-310, 1996